Dancing eyes-dancing feet syndrome
Other Names for this Disease
- Infantile polymyoclonus
- Kinsbourne syndrome
- Opsoclonus myoclonus syndrome
- Polymyoclonus infantile
RDCRN 3rd Conference on Clinical Research for Rare Diseases, Tuesday, October 02, 2012
Location: Hilton Washington DC/Rockville Hotel & Executive Meeting Center, Rockville, MD
Description: Clinical research in rare diseases presents a number of challenges and unique issues that are not usually considered in the training of clinical investigators through existing training programs. Goals of the conference include: direct instruction of trainees and new investigators in rare disease research methodology; development of a reusable curriculum/syllabus on rare disease research methodology; and stimulation of ideas regarding the unique issues facing investigators engaged in the study of rare diseases.
Third Genome Dynamics in the Neurosciences Conference, Sunday, July 18, 2010 - Thursday, July 22, 2010
Location: The Hilton Metropole, Brighton, England
Description: The goal of this meeting was to integrate basic processes of DNA damage signaling and repair and clinical aspects of neurological and neurodegenerative disease. The program was designed to bring together leading scientists with primary interests in DNA damage signaling with those working in specific related neurodegenerative disease areas as a means for integrating these fields. It was anticipated that this would generate insights into how normal processes of genome maintenance in the brain contribute to the prevention of a wide range of diseases.
Opsoclonus Myoclonus Syndrome (OMS) Workshop, Saturday, April 10, 2010 - Saturday, April 10, 2010
Location: The Westin Harbour Castle, Toronto, Ontario, Canada
Description: The goals of the Opsoclonus Myoclonus Syndrome (OMS) Workshop were to discuss the various issues and special challenges that are associated with the diagnosis, prognosis, and treatment of OMS. The objective was to identify strategies to improve research and clinical collaborations and resource sharing in the United States and internationally. Workshop participants also examined the disease course of pediatric and adult onset OMS, discussed current therapeutic strategies, and looked at immune mechanisms of OMS. It was hoped that this workshop would result in the identification of basic and clinical research needs, the setting of research priorities, and facilitatation of the development of clinical protocols.
VI International Conference on Rare Diseases and Orphan Drugs (ICORD 2010): Global Approach to Accessibility in Rare Diseases, Orphan Drugs and Neglected Diseases , Thursday, March 18, 2010 - Saturday, March 20, 2010
Location: Palais Rouge Convention Center, Palermo, Buenos Aires, Argentina
Description: For the first time, the VI International Conference on Rare Diseases and Orphan Drugs (ICORD 2010) was convened in the southern hemisphere in agreement with its aim of globalization of rare diseases research and orphan products development activities.